Novant Health Cancer Institute - Forsyth

Winston-Salem, North Carolina 27103

0 studies enrolling now · 4 studies all time

What they study most

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Chemoradiotherapy-Induced Severe Oral Mucositis, Colorectal Neoplasms, Endometrial Neoplasms, Myelodysplastic Syndromes, Ovarian Neoplasms, PD-L1 Negative, Pancreatic Neoplasms, Triple Negative Breast Cancer

Studies at this site

• Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) — Running, not enrolling
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. — Stopped early